1328 related articles for article (PubMed ID: 19619074)
1. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
Burnier M; Pruijm M; Wuerzner G
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
[TBL] [Abstract][Full Text] [Related]
2. Role of the fixed-dose combination lercanidipine-enalapril in renal protection.
Egan CG; Pontremoli R
J Nephrol; 2011; 24(4):428-37. PubMed ID: 21279953
[TBL] [Abstract][Full Text] [Related]
3. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
Tocci G; Palano F; Pagannone E; Chin D; Ferrucci A; Volpe M
Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207
[TBL] [Abstract][Full Text] [Related]
4. The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalapril.
Chatzikyrkou C; Haller H; Menne J
Expert Opin Pharmacother; 2009 Aug; 10(11):1833-40. PubMed ID: 19527194
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of the fixed lercanidipine-enalapril combination in the treatment of patients with essential hypertension.
Rump LC
Arzneimittelforschung; 2010; 60(3):124-30. PubMed ID: 20422943
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
Antza C; Stabouli S; Kotsis V
Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
[TBL] [Abstract][Full Text] [Related]
7. [Lercanidipine, a third generation calcium antagonist. Which advantages?].
Meier P; Burnier M
Rev Med Suisse; 2006 Sep; 2(78):2047-50, 2052-3. PubMed ID: 17019840
[TBL] [Abstract][Full Text] [Related]
8. Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers.
Makarounas-Kirchmann K; Glover-Koudounas S; Ferrari P
Clin Ther; 2009 Aug; 31(8):1652-63. PubMed ID: 19808126
[TBL] [Abstract][Full Text] [Related]
9. Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension.
Bramlage P
Expert Opin Pharmacother; 2009 Aug; 10(11):1755-67. PubMed ID: 19538001
[TBL] [Abstract][Full Text] [Related]
10. Lercanidipine in the treatment of hypertension.
Beckey C; Lundy A; Lutfi N
Ann Pharmacother; 2007 Mar; 41(3):465-73. PubMed ID: 17341540
[TBL] [Abstract][Full Text] [Related]
11. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
Roberts ME; Epstein BJ
J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
13. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
Ferri C; Croce G; Desideri G
Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
[TBL] [Abstract][Full Text] [Related]
14. Hypertension, possible vascular protection and lercanidipine.
Ram CV
Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):783-8. PubMed ID: 17173495
[TBL] [Abstract][Full Text] [Related]
15. The role of fixed-dose combination therapy with drugs that target the renin-angiotensin system in the hypertension paradigm.
Schmieder RE
Clin Exp Hypertens; 2010 Jan; 32(1):35-42. PubMed ID: 20144071
[TBL] [Abstract][Full Text] [Related]
16. Fixed-dose combination lercanidipine/enalapril.
Hair PI; Scott LJ; Perry CM
Drugs; 2007; 67(1):95-106; discussion 107-8. PubMed ID: 17209666
[TBL] [Abstract][Full Text] [Related]
17. Mitigation of calcium channel blocker-related oedema in hypertension by antagonists of the renin-angiotensin system.
de la Sierra A
J Hum Hypertens; 2009 Aug; 23(8):503-11. PubMed ID: 19148104
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin receptor blocker and dihydropyridine calcium channel blocker combinations: an emerging strategy in hypertension therapy.
Oparil S; Weber M
Postgrad Med; 2009 Mar; 121(2):25-39. PubMed ID: 19332960
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension.
Agrawal R; Marx A; Haller H
J Hypertens; 2006 Jan; 24(1):185-92. PubMed ID: 16331117
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study.
Barrios V; Escobar C; de la Figuera M; Llisterri JL; Honorato J; Segura J; Calderón A
Cardiovasc Ther; 2008; 26(1):2-9. PubMed ID: 18466416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
